purpose of use of proceeds 5. Expansion of production capacity for dietary supplement products, introduction of new product packages, and warehouse building (existing business as disclosed in the
financial institutions 50 50 50 - 2018 4. Working capital for business operations 637.24 637.24 368.34 - 2018-2020 Newly – approved of purpose of use of proceeds 5. Expansion of production capacity for
earnings per share (Baht) (3.49) 0.38 0.16 Note: 1/ EBITDA from Refinery Business of the Company, BCP Trading Pte. Ltd. and share of profit from associated companies 2/ EBITDA from Marketing Business of the
Group 5/ 44 36 (81) -284% -321% 270 24 -91% Others 6/ (76) (72) (61) (113) (190) Profit attributable to owners of the Company 1,060 1,007 1,856 75% 84% 4,137 4,009 -3% Basic earnings per share (Baht) 0.77
holders’ official representative who acts in a fiduciary capacity for the debt securities holders, as well as the provisions applicable to this representation. 2. Disclose the address of the representative
operated full capacity which resulted Methyl Ester(ME) sales volume of 102,754 tons, increased by 33,549 tons or up by 48% yoy, and FA sales volume of 24,235 tons, grew higher by 4,345 tons or up 22% yoy
rebounded to 26.0%, or +350 bps QoQ after capacity debottlenecking. *Net Profit = Net Profit attributable to owners of the parent Financial Performance for Q3’19 and 9M’19 Consolidated Income Statement
to supply such items for others if the capacity is available at any point of times to maximize the benefits and lower production costs in the long run. The new factory is expected to commence the
follows: 1. To approve payment of interim dividend for the operating results of January to June 2017 from net profit and retained earnings under the Company's financial statement, to the shareholders, at an
324.92 285.34 (39.57) (12.18%) 1,060.36 991.54 (68.82) (6.49%) Earnings per share (EPS) 0.20 0.17 (0.02) (12.18%) 0.64 0.60 (0.04) (6.49%) Note: 1) Revenue and Cost that were recognized when there is